• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来氟米特对 RPMI-8226 多发性骨髓瘤细胞系的线粒体非依赖性细胞毒性作用。

The Mitochondria-Independent Cytotoxic Effect of Leflunomide on RPMI-8226 Multiple Myeloma Cell Line.

机构信息

Independent Medical Biology Unit, Faculty of Pharmacy, Medical University of Lublin, 20-093 Lublin, Poland.

Department of Toxicology, Faculty of Pharmacy, Medical University of Lublin, 20-093 Lublin, Poland.

出版信息

Molecules. 2021 Sep 17;26(18):5653. doi: 10.3390/molecules26185653.

DOI:10.3390/molecules26185653
PMID:34577124
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8469018/
Abstract

Leflunomide, an anti-inflammatory agent, has been shown to be effective in multiple myeloma (MM) treatment; however, the mechanism of this phenomenon has not been fully elucidated. The aim of the study was to assess the role of mitochondria and dihydroorotate dehydrogenase (DHODH) inhibition in the cytotoxicity of leflunomide in relation to the MM cell line RPMI 8226. The cytotoxic effect of teriflunomide-an active metabolite of leflunomide-was determined using MTT assay, apoptosis detection, and cell cycle analysis. To evaluate DHODH-dependent toxicity, the cultures treated with teriflunomide were supplemented with uridine. Additionally, the level of cellular thiols as oxidative stress symptom was measured as well as mitochondrial membrane potential and protein tyrosine kinases (PTK) activity. The localization of the compound in cell compartments was examined using HPLC method. Teriflunomide cytotoxicity was not abolished in uridine presence. Observed apoptosis occurred in a mitochondria-independent manner, there was also no decrease in cellular thiols level. Teriflunomide arrested cell cycle in the G2/M phase which is not typical for DHODH deficiency. PTK activity was decreased only at the highest drug concentration. Interestingly, teriflunomide was not detected in the mitochondria. The aforementioned results indicate DHODH- and mitochondria-independent mechanism of leflunomide toxicity against RPMI 8226 cell line.

摘要

来氟米特是一种抗炎剂,已被证明在多发性骨髓瘤(MM)治疗中有效;然而,其作用机制尚未完全阐明。本研究旨在评估线粒体和二氢乳清酸脱氢酶(DHODH)抑制在来氟米特对 RPMI 8226 骨髓瘤细胞系的细胞毒性中的作用。使用 MTT 测定法、细胞凋亡检测和细胞周期分析来确定来氟米特的活性代谢物特立氟胺的细胞毒性作用。为了评估 DHODH 依赖性毒性,用特立氟胺处理的培养物中添加尿苷。此外,还测量了细胞硫醇水平作为氧化应激症状,以及线粒体膜电位和蛋白酪氨酸激酶(PTK)活性。使用 HPLC 方法检查了化合物在细胞区室中的定位。尿苷存在时,特立氟胺的细胞毒性未被消除。观察到的细胞凋亡是一种与线粒体无关的方式发生的,细胞硫醇水平也没有下降。特立氟胺将细胞周期阻滞在 G2/M 期,这与 DHODH 缺乏不同。仅在最高药物浓度时,PTK 活性降低。有趣的是,在线粒体中未检测到特立氟胺。上述结果表明,来氟米特对 RPMI 8226 细胞系的毒性作用具有 DHODH 和线粒体非依赖性机制。

相似文献

1
The Mitochondria-Independent Cytotoxic Effect of Leflunomide on RPMI-8226 Multiple Myeloma Cell Line.来氟米特对 RPMI-8226 多发性骨髓瘤细胞系的线粒体非依赖性细胞毒性作用。
Molecules. 2021 Sep 17;26(18):5653. doi: 10.3390/molecules26185653.
2
Efficacy and safety of dihydroorotate dehydrogenase (DHODH) inhibitors "leflunomide" and "teriflunomide" in Covid-19: A narrative review.二氢乳清酸脱氢酶(DHODH)抑制剂“来氟米特”和“特立氟胺”在新冠病毒感染中的疗效和安全性:一项叙述性综述。
Eur J Pharmacol. 2021 Sep 5;906:174233. doi: 10.1016/j.ejphar.2021.174233. Epub 2021 Jun 7.
3
Effect of the Intramolecular Hydrogen Bond on the Active Metabolite Analogs of Leflunomide for Blocking the Plasmodium falciparum Dihydroorotate Dehydrogenase Enzyme: QTAIM, NBO, and Docking Study.分子内氢键对来氟米特活性代谢物类似物阻断恶性疟原虫二氢乳清酸脱氢酶的影响:QTAIM、NBO和对接研究
Curr Comput Aided Drug Des. 2021;17(3):480-491. doi: 10.2174/1573409916666200527133126.
4
Investigating dihydroorotate dehydrogenase inhibitor mediated mitochondrial dysfunction in hepatic in vitro models.研究二氢乳清酸脱氢酶抑制剂介导的肝体外模型中线粒体功能障碍。
Toxicol In Vitro. 2021 Apr;72:105096. doi: 10.1016/j.tiv.2021.105096. Epub 2021 Jan 16.
5
Precision Medicine With Leflunomide: Consideration of the DHODH Haplotype and Plasma Teriflunomide Concentration and Modification of Outcomes in Patients With Rheumatoid Arthritis.来氟米特精准医学:考虑 DHODH 单倍型和血浆特立氟胺浓度,并对类风湿关节炎患者的结局进行修饰。
Arthritis Care Res (Hoboken). 2021 Jul;73(7):983-989. doi: 10.1002/acr.24236.
6
Dihydroorotate dehydrogenase inhibitor A771726 (leflunomide) induces apoptosis and diminishes proliferation of multiple myeloma cells.二氢乳清酸脱氢酶抑制剂A771726(来氟米特)诱导多发性骨髓瘤细胞凋亡并减少其增殖。
Mol Cancer Ther. 2009 Feb;8(2):366-75. doi: 10.1158/1535-7163.MCT-08-0664. Epub 2009 Jan 27.
7
Development of a biomarker to monitor target engagement after treatment with dihydroorotate dehydrogenase inhibitors.开发一种生物标志物,用于监测二氢乳清酸脱氢酶抑制剂治疗后的靶标结合情况。
Biochem Pharmacol. 2022 Oct;204:115237. doi: 10.1016/j.bcp.2022.115237. Epub 2022 Aug 31.
8
Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects.特立氟胺治疗多发性硬化症可调节 T 细胞线粒体呼吸,具有亲和力依赖性作用。
Sci Transl Med. 2019 May 1;11(490). doi: 10.1126/scitranslmed.aao5563.
9
Teriflunomide Preserves Neuronal Activity and Protects Mitochondria in Brain Slices Exposed to Oxidative Stress.噻氟酰胺可维持氧化应激状态下脑切片的神经元活性并保护线粒体。
Int J Mol Sci. 2022 Jan 28;23(3):1538. doi: 10.3390/ijms23031538.
10
Inhibition of canine distemper virus replication by blocking pyrimidine nucleotide synthesis with A77 1726, the active metabolite of the anti-inflammatory drug leflunomide.用抗炎药物来氟米特的活性代谢产物 A77 1726 阻断嘧啶核苷酸合成抑制犬瘟热病毒复制。
J Gen Virol. 2021 Mar;102(3). doi: 10.1099/jgv.0.001534. Epub 2021 Jan 8.

本文引用的文献

1
DHODH and cancer: promising prospects to be explored.二氢乳清酸脱氢酶与癌症:有待探索的广阔前景
Cancer Metab. 2021 May 10;9(1):22. doi: 10.1186/s40170-021-00250-z.
2
Teriflunomide preserves peripheral nerve mitochondria from oxidative stress-mediated alterations.特立氟胺可保护周围神经线粒体免受氧化应激介导的改变。
Ther Adv Chronic Dis. 2020 Aug 11;11:2040622320944773. doi: 10.1177/2040622320944773. eCollection 2020.
3
A77 1726, the active metabolite of the anti-rheumatoid arthritis drug leflunomide, inhibits influenza A virus replication in vitro and in vivo by inhibiting the activity of Janus kinases.
A77 1726,抗风湿药来氟米特的活性代谢物,通过抑制 Janus 激酶的活性,在体外和体内抑制流感 A 病毒的复制。
FASEB J. 2020 Aug;34(8):10132-10145. doi: 10.1096/fj.201902793RR. Epub 2020 Jun 29.
4
Leflunomide Inhibits Proliferation and Induces Apoptosis via Suppressing Autophagy and PI3K/Akt Signaling Pathway in Human Bladder Cancer Cells.来氟米特通过抑制自噬和 PI3K/Akt 信号通路抑制人膀胱癌细胞增殖并诱导其凋亡。
Drug Des Devel Ther. 2020 May 18;14:1897-1908. doi: 10.2147/DDDT.S252626. eCollection 2020.
5
Repurposing leflunomide for relapsed/refractory multiple myeloma: a phase 1 study.来氟米特用于复发/难治性多发性骨髓瘤的重新利用:一项1期研究。
Leuk Lymphoma. 2020 Jul;61(7):1669-1677. doi: 10.1080/10428194.2020.1742900. Epub 2020 Apr 8.
6
Dysregulation of de novo nucleotide biosynthetic pathway enzymes in cancer and targeting opportunities.癌症中从头核苷酸生物合成途径酶的失调及其靶向治疗机会。
Cancer Lett. 2020 Feb 1;470:134-140. doi: 10.1016/j.canlet.2019.11.013. Epub 2019 Nov 13.
7
Leflunomide regulates c-Myc expression in myeloma cells through PIM targeting.来氟米特通过靶向 PIM 调节骨髓瘤细胞中的 c-Myc 表达。
Blood Adv. 2019 Apr 9;3(7):1027-1032. doi: 10.1182/bloodadvances.2018027227.
8
Haematology: multiple myeloma.血液学:多发性骨髓瘤。
Clin Med (Lond). 2019 Jan;19(1):58-60. doi: 10.7861/clinmedicine.19-1-58.
9
Leflunomide attenuates oxidative stress in fetal human lung endothelial cells via superoxide dismutase 2 and catalase.来氟米特通过超氧化物歧化酶 2 和过氧化氢酶减轻胎儿人肺内皮细胞的氧化应激。
Biochem Biophys Res Commun. 2018 Sep 10;503(3):2009-2014. doi: 10.1016/j.bbrc.2018.07.149. Epub 2018 Aug 2.
10
Mitochondrial dysfunction induced by leflunomide and its active metabolite.来氟米特及其活性代谢物引起的线粒体功能障碍。
Toxicology. 2018 Mar 1;396-397:33-45. doi: 10.1016/j.tox.2018.02.003. Epub 2018 Feb 8.